Key facts
- Democratic candidates are being cautioned by advisers to avoid strong positions on AI regulation.
- Leading the Future, a pro-AI super PAC backed by OpenAI investors, spent over $25 million in primary races.
- Public First Action, funded by OpenAI competitor Anthropic, advocates for AI regulation.
- Leading the Future spokesperson Josh Vlasto accused Public First and Anthropic-funded groups of intimidation tactics.
- Leading the Future is spending $2 million to boost four Republican Senate candidates in marginally competitive races.
- Public First Action uses 'export controls' and 'opposition to preemption of state laws regarding AI' as criteria for supporting candidates.
Democratic candidates and their campaigns are reportedly being advised to tread carefully on artificial intelligence policy to avoid alienating powerful tech-focused super PACs. This comes as major AI companies and their backers are increasingly involved in political spending, creating a complex landscape for politicians.
Two prominent super PACs, Leading the Future and Public First Action, are at odds over AI regulation. Leading the Future, backed by investors and executives from OpenAI, spent over $25 million in primary races this year. Its spokesperson, Josh Vlasto, accused rival groups funded by Anthropic, OpenAI's competitor, of using "intimidation tactics" against members of Congress.
Leading the Future recently launched its first general election ads, spending $2 million to support four Republican Senate candidates in marginally competitive races. Meanwhile, Public First Action, which advocates for AI regulation, uses specific criteria to decide where to intervene in races. Co-founder Brad Carson stated that candidates showing "strong support for export controls and strong opposition to the preemption of state laws regarding AI, absent a federal framework," are prime candidates for their support. The two groups have previously clashed in primary races, and Democrats anticipate they may compete again in key general election contests.